A 31-year-old primigravid woman comes to the physician for a prenatal visit. She is known to be HIV positive. She also has asthma, for which she uses an inhaler. She had a diagnostic laparoscopy at age 20 for pelvic pain and has had no other surgeries. She has no known drug allergies. Extensive counseling is given to the patient regarding veical transmission of HIV to the fetus. It is recommended to her that she take antiretroviral therapy during the pregnancy to decrease the veical transmission rate. It is also recommended to her that she have a scheduled cesarean delivery. After consideration of these options, the patient chooses not to take the antiretrovirals and opts for a vaginal delivery. This of the following represents the approximate risk of veical transmission (from the mother to the fetus) for this patient?
A 31-year-old primigravid woman comes to the physician for a prenatal visit. She is known to be HIV positive. She also has asthma, for which she uses an inhaler. She had a diagnostic laparoscopy at age 20 for pelvic pain and has had no other surgeries. She has no known drug allergies. Extensive counseling is given to the patient regarding veical transmission of HIV to the fetus. It is recommended to her that she take antiretroviral therapy during the pregnancy to decrease the veical transmission rate. It is also recommended to her that she have a scheduled cesarean delivery. After consideration of these options, the patient chooses not to take the antiretrovirals and opts for a vaginal delivery. This of the following represents the approximate risk of veical transmission (from the mother to the fetus) for this patient?
💡 Explanation
**Core Concept**
Without antiretroviral therapy, the risk of mother-to-child transmission (MTCT) of HIV during vaginal delivery is significantly higher compared to scheduled cesarean delivery. This is due to the exposure of the fetus to the mother's blood and other bodily fluids during delivery.
**Why the Correct Answer is Right**
The risk of MTCT of HIV is influenced by several factors, including the mother's viral load, mode of delivery, and use of antiretroviral therapy. In the absence of antiretroviral therapy, the risk of MTCT of HIV during vaginal delivery is estimated to be around 20-30%. This is because the fetus is exposed to the mother's blood and other bodily fluids during delivery, which can contain high levels of HIV. Scheduled cesarean delivery, on the other hand, can reduce the risk of MTCT of HIV by approximately 50-70% by avoiding the exposure of the fetus to the mother's blood and other bodily fluids during delivery.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided.
**Option B:** There is no specific data to support this risk estimate.
**Option C:** This option is not accurate, as the risk of MTCT of HIV during vaginal delivery without antiretroviral therapy is significantly higher than this estimate.
**Clinical Pearl / High-Yield Fact**
It is essential to note that the American College of Obstetricians and Gynecologists (ACOG) recommends that all HIV-positive women receive antiretroviral therapy during pregnancy to reduce the risk of MTCT of HIV. Scheduled cesarean delivery is also recommended for HIV-positive women with a high viral load or those who are not receiving antiretroviral therapy.
**Correct Answer:** 20-30%
✓ Correct Answer: C. 25%
📤 Share this MCQ
Share Card Preview
👆 1080x1080 square card — fills the full width in WhatsApp and Telegram